Litcius/Paper detail

Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy

Liang Zhao, Jianhao Chen, Yizhen Pang, Jianyang Fang, Kaili Fu, Lingxin Meng, Xianzhong Zhang, Zhide Guo, Hua Wu, Long Sun, Guoqiang Su, Qin Lin, Haojun Chen

2022Molecular Pharmaceutics44 citationsDOI

Abstract

may be safe and effective for the treatment of FAP-positive malignant tumors.

Topics & Concepts

Fibroblast activation protein, alphaChemistryCancer researchFibroblastPharmacologyBiochemistryCancerMedicineIn vitroInternal medicinePeptidase Inhibition and AnalysisProtease and Inhibitor MechanismsCardiac Structural Anomalies and Repair
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy | Litcius